Utility of a rectal suppository containing the antiepileptic drug zonisamide

Aki Nagatomi, Motohiro Mishima, Osami Tsuzuki, Shigehiro Ohdo, Shun Higuchi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A suppository of zonisamide (ZNS) was investigated from the viewpoint of pharmaceutical evaluation, pharmacokinetics and pharmacological effect. Two types of ZNS suppositories were prepared. One used Witepsol (H-15: S-55 = 3:1) as a lipophilic base and the other polyethylene glycol (PEG, 4000:1500 = 4:1) as a hydrophilic base. The in vitro release rate of ZNS from the PEG suppository was significantly rapid compared with that of ZNS from Witepsol. Male Wistar rats were administered ZNS (20 mg/kg) using an intravenous, oral or rectal (PEG or Witepsol) route. The absorption of ZNS from the PEG suppository was more rapid than that of ZNS from the Witepsol suppository or from the oral preparation. The peak plasma concentration (C(max)) after a rectal administration of ZNS with Witepsol or PEG suppository was significantly higher than that after the oral administration of ZNS. However, the bioavailability of the three preparations was approximately 100%. Male ICR mice were administered ZNS (80 mg/kg) using the oral or rectal (PEG or Witepsol) route. A positive correlation was observed between the electroshock seizure (ES) threshold and ZNS concentration in plasma or brain. Further, there was no significant difference in the ES threshold or the ZNS concentration in plasma or brain among the three preparations. These results indicate that a ZNS suppository is a very useful preparation from the viewpoint of both pharmacokinetics and pharmacological action.

Original languageEnglish
Pages (from-to)892-896
Number of pages5
JournalBiological and Pharmaceutical Bulletin
Volume20
Issue number8
DOIs
Publication statusPublished - Jan 1 1997

Fingerprint

zonisamide
Suppositories
Anticonvulsants
Electroshock
Seizures

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Utility of a rectal suppository containing the antiepileptic drug zonisamide. / Nagatomi, Aki; Mishima, Motohiro; Tsuzuki, Osami; Ohdo, Shigehiro; Higuchi, Shun.

In: Biological and Pharmaceutical Bulletin, Vol. 20, No. 8, 01.01.1997, p. 892-896.

Research output: Contribution to journalArticle

Nagatomi, Aki ; Mishima, Motohiro ; Tsuzuki, Osami ; Ohdo, Shigehiro ; Higuchi, Shun. / Utility of a rectal suppository containing the antiepileptic drug zonisamide. In: Biological and Pharmaceutical Bulletin. 1997 ; Vol. 20, No. 8. pp. 892-896.
@article{4fe97e643d3347fc9a4395ec7dc40ac9,
title = "Utility of a rectal suppository containing the antiepileptic drug zonisamide",
abstract = "A suppository of zonisamide (ZNS) was investigated from the viewpoint of pharmaceutical evaluation, pharmacokinetics and pharmacological effect. Two types of ZNS suppositories were prepared. One used Witepsol (H-15: S-55 = 3:1) as a lipophilic base and the other polyethylene glycol (PEG, 4000:1500 = 4:1) as a hydrophilic base. The in vitro release rate of ZNS from the PEG suppository was significantly rapid compared with that of ZNS from Witepsol. Male Wistar rats were administered ZNS (20 mg/kg) using an intravenous, oral or rectal (PEG or Witepsol) route. The absorption of ZNS from the PEG suppository was more rapid than that of ZNS from the Witepsol suppository or from the oral preparation. The peak plasma concentration (C(max)) after a rectal administration of ZNS with Witepsol or PEG suppository was significantly higher than that after the oral administration of ZNS. However, the bioavailability of the three preparations was approximately 100{\%}. Male ICR mice were administered ZNS (80 mg/kg) using the oral or rectal (PEG or Witepsol) route. A positive correlation was observed between the electroshock seizure (ES) threshold and ZNS concentration in plasma or brain. Further, there was no significant difference in the ES threshold or the ZNS concentration in plasma or brain among the three preparations. These results indicate that a ZNS suppository is a very useful preparation from the viewpoint of both pharmacokinetics and pharmacological action.",
author = "Aki Nagatomi and Motohiro Mishima and Osami Tsuzuki and Shigehiro Ohdo and Shun Higuchi",
year = "1997",
month = "1",
day = "1",
doi = "10.1248/bpb.20.892",
language = "English",
volume = "20",
pages = "892--896",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "8",

}

TY - JOUR

T1 - Utility of a rectal suppository containing the antiepileptic drug zonisamide

AU - Nagatomi, Aki

AU - Mishima, Motohiro

AU - Tsuzuki, Osami

AU - Ohdo, Shigehiro

AU - Higuchi, Shun

PY - 1997/1/1

Y1 - 1997/1/1

N2 - A suppository of zonisamide (ZNS) was investigated from the viewpoint of pharmaceutical evaluation, pharmacokinetics and pharmacological effect. Two types of ZNS suppositories were prepared. One used Witepsol (H-15: S-55 = 3:1) as a lipophilic base and the other polyethylene glycol (PEG, 4000:1500 = 4:1) as a hydrophilic base. The in vitro release rate of ZNS from the PEG suppository was significantly rapid compared with that of ZNS from Witepsol. Male Wistar rats were administered ZNS (20 mg/kg) using an intravenous, oral or rectal (PEG or Witepsol) route. The absorption of ZNS from the PEG suppository was more rapid than that of ZNS from the Witepsol suppository or from the oral preparation. The peak plasma concentration (C(max)) after a rectal administration of ZNS with Witepsol or PEG suppository was significantly higher than that after the oral administration of ZNS. However, the bioavailability of the three preparations was approximately 100%. Male ICR mice were administered ZNS (80 mg/kg) using the oral or rectal (PEG or Witepsol) route. A positive correlation was observed between the electroshock seizure (ES) threshold and ZNS concentration in plasma or brain. Further, there was no significant difference in the ES threshold or the ZNS concentration in plasma or brain among the three preparations. These results indicate that a ZNS suppository is a very useful preparation from the viewpoint of both pharmacokinetics and pharmacological action.

AB - A suppository of zonisamide (ZNS) was investigated from the viewpoint of pharmaceutical evaluation, pharmacokinetics and pharmacological effect. Two types of ZNS suppositories were prepared. One used Witepsol (H-15: S-55 = 3:1) as a lipophilic base and the other polyethylene glycol (PEG, 4000:1500 = 4:1) as a hydrophilic base. The in vitro release rate of ZNS from the PEG suppository was significantly rapid compared with that of ZNS from Witepsol. Male Wistar rats were administered ZNS (20 mg/kg) using an intravenous, oral or rectal (PEG or Witepsol) route. The absorption of ZNS from the PEG suppository was more rapid than that of ZNS from the Witepsol suppository or from the oral preparation. The peak plasma concentration (C(max)) after a rectal administration of ZNS with Witepsol or PEG suppository was significantly higher than that after the oral administration of ZNS. However, the bioavailability of the three preparations was approximately 100%. Male ICR mice were administered ZNS (80 mg/kg) using the oral or rectal (PEG or Witepsol) route. A positive correlation was observed between the electroshock seizure (ES) threshold and ZNS concentration in plasma or brain. Further, there was no significant difference in the ES threshold or the ZNS concentration in plasma or brain among the three preparations. These results indicate that a ZNS suppository is a very useful preparation from the viewpoint of both pharmacokinetics and pharmacological action.

UR - http://www.scopus.com/inward/record.url?scp=0030758346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030758346&partnerID=8YFLogxK

U2 - 10.1248/bpb.20.892

DO - 10.1248/bpb.20.892

M3 - Article

C2 - 9300137

AN - SCOPUS:0030758346

VL - 20

SP - 892

EP - 896

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 8

ER -